Iwao Yamada

888 total citations
18 papers, 691 citations indexed

About

Iwao Yamada is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Iwao Yamada has authored 18 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Iwao Yamada's work include Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Chemical Synthesis and Analysis (3 papers). Iwao Yamada is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Chemical Synthesis and Analysis (3 papers). Iwao Yamada collaborates with scholars based in Japan, United States and Russia. Iwao Yamada's co-authors include Hideki Fujino, Masanori Aikawa, Elena Aïkawa, Claudia Goettsch, J. Kojima, Noritaka Chida, Junji Kojima, Sasha A. Singh, Natalia Maldonado and Hiroshi Iwata and has published in prestigious journals such as Nature Communications, Circulation Research and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Iwao Yamada

18 papers receiving 676 citations

Peers

Countries citing papers authored by Iwao Yamada

Since Specialization

Citations

This map shows the geographic impact of Iwao Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwao Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwao Yamada more than expected).

Fields of papers citing papers by Iwao Yamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwao Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwao Yamada. The network helps show where Iwao Yamada may publish in the future.

Co-authorship network of co-authors of Iwao Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Iwao Yamada. A scholar is included among the top collaborators of Iwao Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwao Yamada. Iwao Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Multiorgan Systems Study Reveals Igfbp7 as a Suppressor of Gluconeogenesis after Gastric Bypass Surgery 2019 ·Journal of Proteome Research ·Naoaki Arima, Yusuke Sasaki, Lang Ho Lee, Hengmin Zhang, Jose‐Luiz Figueiredo, (unknown), Jiao Qiao, Iwao Yamada, Hideyuki Higashi, (unknown), Arda Halu, Ken Mizuno, Sasha A. Singh, (unknown), Masanori Aikawa	2
2	Dynamin-Related Protein 1 Inhibition Attenuates Cardiovascular Calcification in the Presence of Oxidative Stress 2017 ·Circulation Research ·Maximillian A. Rogers, Natalia Maldonado, Joshua D. Hutcheson, Claudia Goettsch, Shinji Goto, Iwao Yamada, Tyler Faits, Hiromi Sesaki, Masanori Aikawa, Elena Aïkawa	100
3	PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation 2016 ·Nature Communications ·Hiroshi Iwata, Claudia Goettsch, Amitabh Sharma, Piero Ricchiuto, Wilson Wen Bin Goh, Arda Halu, Iwao Yamada, Hideo Yoshida, Takuya Hara, Wei Mei, Noriyuki Inoue, Daiju Fukuda, (unknown), (unknown), Albert-Ĺaszló Barabási, Mark Boothby, Elena Aïkawa, Sasha A. Singh, Masanori Aikawa	207
4	mIMT-visHTS: A novel method for multiplexing isobaric mass tagged datasets with an accompanying visualization high throughput screening tool for protein profiling 2015 ·Journal of Proteomics ·Piero Ricchiuto, Hiroshi Iwata, Katsumi Yabusaki, Iwao Yamada, (unknown), Amitabh Sharma, Masanori Aikawa, Sasha A. Singh	6
5	Cystathionine γ-lyase Accelerates Osteoclast Differentiation 2013 ·Arteriosclerosis Thrombosis and Vascular Biology ·Takahiro Ito, Natalia Maldonado, Iwao Yamada, Claudia Goettsch, Jiro Matsumoto, Masanori Aikawa, Sasha A. Singh, Elena Aïkawa	31
6	Studies on the Interaction between Fibrates and Statins Using Human Hepatic Microsomes 2011 ·Arzneimittelforschung ·Hideki Fujino, (unknown), Iwao Yamada, Masaru Hirano, (unknown), Junji Kojima	12
7	Metabolic Fate of Pitavastatin (NK-104), a New Inhibitor of 3-Hydroxy-3-methyllutaryl Coenzyme A Reductase 2011 ·Arzneimittelforschung ·Hideki Fujino, Iwao Yamada, (unknown), (unknown), (unknown)	16
8	INTERACTION BETWEEN FIBRATES AND STATINS - METABOLIC INTERACTIONS WITH GEMFIBROZIL 2003 ·Drug metabolism and drug interactions ·Hideki Fujino, Iwao Yamada, (unknown), Masaru Hirano, (unknown), Junji Kojima	19
9	Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans 2003 ·Xenobiotica ·Iwao Yamada, Hideki Fujino, (unknown), J. Kojima	25
10	Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization 2003 ·Xenobiotica ·Hideki Fujino, Iwao Yamada, (unknown), (unknown), J. Kojima	85
11	Metabolic Fate of Pitavastatin, a New Inhibitor of HMG-CoA Reductase—Effect of cMOAT Deficiency on Hepatobiliary Excretion in Rats and of mdr 1a/b Gene Disruption on Tissue Distribution in Mice 2002 ·Drug Metabolism and Pharmacokinetics ·Hideki Fujino, Iwao Yamada, (unknown), Junji Kojima	26
12	Total Synthesis of Spicamycin 2002 ·The Journal of Organic Chemistry ·(unknown), Sayaka Suzuki, Iwao Yamada, (unknown), (unknown), Noritaka Chida	61
13	Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Is the metabolism of pitavastatin in monkey similar to that in human? 2001 ·Iwao Yamada, Hideki Fujino, (unknown), (unknown)	1
14	Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay — inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase 2001 ·Journal of Chromatography B Biomedical Sciences and Applications ·Hideki Fujino, Iwao Yamada, (unknown), (unknown)	24
15	Studies on the metabolic fate of itavastatin, a new inhibitor of HMG-CoA reductase-in vitro metabolism 2000 ·Atherosclerosis ·Hideki Fujino, Iwao Yamada, (unknown), Hiromichi Matsumoto, (unknown)	4
16	Total Synthesis of Spicamycin Amino Nucleoside 2000 ·Organic Letters ·(unknown), (unknown), Iwao Yamada, (unknown), (unknown), Noritaka Chida	24
17	Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (5). In Vitro Metabolism and Plasma Protein Binding in Animals and Human. 1999 ·Drug Metabolism and Pharmacokinetics ·Hideki Fujino, Iwao Yamada, Junji Kojima, Masaru Hirano, Hiroo Matsumoto, (unknown)	29
18	Pd-Catalyzed coupling reaction of glycosylamines with 6-chloropurines: Synthesis of 6-(β-d-mannopyranosylamino)-9H-purine and its β-d-gluco isomer, N-glycoside models for spicamycin and septacidin 1999 ·Tetrahedron Letters ·Noritaka Chida, (unknown), (unknown), Iwao Yamada	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact